BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24480244)

  • 21. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related androgen deficiency and type 2 diabetes.
    Ryan GJ; Jobe LJ
    J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation.
    Giltay EJ; Haider A; Saad F; Gooren LJ
    Andrologia; 2008 Dec; 40(6):398-400. PubMed ID: 19032692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of testosterone in women.
    Panay N; Fenton A
    Climacteric; 2009 Jun; 12(3):185-7. PubMed ID: 19437195
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypogonadism, hyperprolactinaemia, and temporal lobe epilepsy in hyposexual men.
    Spark RF; Wills CA; Royal H
    Lancet; 1984 Feb; 1(8374):413-7. PubMed ID: 6142149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
    Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
    Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone supplementation in women: prescribing practices in one community.
    Freeman MP
    J Womens Health (Larchmt); 2004 Mar; 13(2):239-40. PubMed ID: 15072739
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of male hormone on libido in impuberism and hypogonadism at the age of 20 years].
    Gautier D; Le Van F; Fromantin M
    Probl Actuels Endocrinol Nutr; 1977; (21):57-67. PubMed ID: 617231
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
    Barton DL; Wender DB; Sloan JA; Dalton RJ; Balcueva EP; Atherton PJ; Bernath AM; DeKrey WL; Larson T; Bearden JD; Carpenter PC; Loprinzi CL
    J Natl Cancer Inst; 2007 May; 99(9):672-9. PubMed ID: 17470735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sexual function rehabilitation of men with pituitary tumors].
    Rozhivanov RV; Kurbatov DG
    Urologiia; 2010; (4):48, 50-3. PubMed ID: 20973135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Men, androgen deficiency, and pharmaceutical promotion.
    Finucane TE
    Arch Intern Med; 2009 Jan; 169(1):88; author reply 88-9. PubMed ID: 19139331
    [No Abstract]   [Full Text] [Related]  

  • 32. Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment.
    Trabado S; Maione L; Salenave S; Baron S; Galland F; Bry-Gauillard H; Guiochon-Mantel A; Chanson P; Pitteloud N; Sinisi AA; Brailly-Tabard S; Young J
    Fertil Steril; 2011 Jun; 95(7):2324-9, 2329.e1-3. PubMed ID: 21536274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone replacement in older men and women.
    Morley JE
    J Gend Specif Med; 2001; 4(2):49-53. PubMed ID: 11480098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of accurate testosterone testing in the treatment and management of male hypogonadism.
    Dobs AS
    Steroids; 2008 Dec; 73(13):1305-10. PubMed ID: 18639568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone therapy in hypogonadal men. Introduction.
    Kaminetsky JC
    Clin Cornerstone; 2005; 7 Suppl 4():S5-7. PubMed ID: 16651206
    [No Abstract]   [Full Text] [Related]  

  • 37. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: can a case be made for a 3-month therapeutic trial?
    Black AM; Day AG; Morales A
    BJU Int; 2004 Nov; 94(7):1066-70. PubMed ID: 15541129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations.
    Nieschlag E; Swerdloff R; Behre HM; Gooren LJ; Kaufman JM; Legros JJ; Lunenfeld B; Morley JE; Schulman C; Wang C; Weidner W; Wu FC; ; ;
    Eur Urol; 2005 Jul; 48(1):1-4. PubMed ID: 15951102
    [No Abstract]   [Full Text] [Related]  

  • 40. Treating low sexual desire - new findings for testosterone in women.
    Heiman JR
    N Engl J Med; 2008 Nov; 359(19):2047-9. PubMed ID: 18987373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.